Prosecution Insights
Last updated: November 16, 2026

NeuroPace Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

NeuroPace Inc. currently manages a concentrated patent portfolio within the Medical Devices & Mechanical Engineering technology area. The data shows 1 pending office action across the entire portfolio, indicating a very specific point of engagement with the patent office. This matter is handled by 1 distinct examiner, which reflects a narrow channel of prosecution for the company at this stage.

The prosecution activity is localized within 1 distinct art unit. This concentration suggests that the current legal challenges or examinations are confined to a specific technical niche within the broader sector. BAIG, RUMAISA RASHID is identified as the busiest examiner for this portfolio, currently overseeing 1 pending office action in that capacity. Because this individual is responsible for the only active matter, the immediate outcome of the portfolio's prosecution rests entirely on this single interaction.

Practitioners should note that with only the current distinct examiner and art unit involved, there is no diversity in the examination perspectives currently being applied to the company's filings. A strategy focused on the pending office action is required to move the portfolio forward. This streamlined activity under BAIG, RUMAISA RASHID allows for a very focused approach to resolving outstanding issues within the relevant domain.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAIG, RUMAISA RASHID 1 36.0% +30.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17709195 SYSTEMS AND METHODS FOR OBTAINING AND PRESENTING CLINICAL RESPONSE INFORMATION USING MACHINE-LEARNED MODELS TRAINED ON IMPLANTED NEUROSTIMULATOR DATA BAIG, RUMAISA RASHID —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17709195 SYSTEMS AND METHODS FOR OBTAINING AND PRESENTING CLINICAL RESPONSE INFORMATION USING MACHINE-LEARNED MODELS TRAINED ON IMPLANTED NEUROSTIMULATOR DATA BAIG, RUMAISA RASHID —

Top Art Units

Art UnitApps
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17709195 SYSTEMS AND METHODS FOR OBTAINING AND PRESENTING CLINICAL RESPONSE INFORMATION USING MACHINE-LEARNED MODELS TRAINED ON IMPLANTED NEUROSTIMULATOR DATA BAIG, RUMAISA RASHID 3792 §103§112 Final Rejection — Pending Mar 30, 2022

Managing NeuroPace Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does NeuroPace Inc. have?

NeuroPace Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most NeuroPace Inc. applications?

Rumaisa Rashid Baig has the most, with 1 of NeuroPace Inc.'s pending office actions.

What technology area are NeuroPace Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month